Key facts
- Datavant’s last known valuation is $7.0B (Jul 2021).
- It has raised $83.0M; the latest was Merger/Acquisition in Dec 2025.
- Notable investors include KittyHawk, Oxeon Partners, Town Hall Ventures, New Mountain Capital, Ardan Equity.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Datavant
- ·The full record, as it builds
Funding rounds
No funding rounds for Datavant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Datavant
Developer of a privacy-preserving health data collaboration platform designed to make the world's health data secure, accessible, and actionable. The company's health data platform provides services including release of information, health data retrieval, and data linkage solutions, thereby enabling healthcare organizations to securely connect proprietary and real-world data for research, care, and analytics.
- Sector
- Healthcare
- HQ
- Phoenix, AZ, United States
- Employees
- 6,978
- Website
- datavant.com/
- Ownership
- Privately Held (backing)
Datavant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Datavant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Datavant in its N-PORT filings yet. We sweep new filings monthly.